These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24362329)
21. In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. Athamna A; Massalha M; Athamna M; Nura A; Medlej B; Ofek I; Bast D; Rubinstein E J Antimicrob Chemother; 2004 Feb; 53(2):247-51. PubMed ID: 14688054 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary. Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086 [TBL] [Abstract][Full Text] [Related]
24. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989 [TBL] [Abstract][Full Text] [Related]
25. Existence of separate domains in lysin PlyG for recognizing Bacillus anthracis spores and vegetative cells. Yang H; Wang DB; Dong Q; Zhang Z; Cui Z; Deng J; Yu J; Zhang XE; Wei H Antimicrob Agents Chemother; 2012 Oct; 56(10):5031-9. PubMed ID: 22802245 [TBL] [Abstract][Full Text] [Related]
26. Interactions of antimicrobial peptide chrysophsin-3 with Bacillus anthracis in sporulated, germinated, and vegetative states. Pinzón-Arango PA; Nagarajan R; Camesano TA J Phys Chem B; 2013 May; 117(21):6364-72. PubMed ID: 23631815 [TBL] [Abstract][Full Text] [Related]
27. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis. Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Bacillus anthracis spore outgrowth by nisin. Gut IM; Prouty AM; Ballard JD; van der Donk WA; Blanke SR Antimicrob Agents Chemother; 2008 Dec; 52(12):4281-8. PubMed ID: 18809941 [TBL] [Abstract][Full Text] [Related]
29. Germination and persistence of Bacillus anthracis and Bacillus thuringiensis in soil microcosms. Bishop AH J Appl Microbiol; 2014 Nov; 117(5):1274-82. PubMed ID: 25099131 [TBL] [Abstract][Full Text] [Related]
31. Selection of Bacillus anthracis isolates resistant to antibiotics. Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405 [TBL] [Abstract][Full Text] [Related]
32. Green tea and epigallocatechin-3-gallate are bactericidal against Bacillus anthracis. Falcinelli SD; Shi MC; Friedlander AM; Chua J FEMS Microbiol Lett; 2017 Jul; 364(12):. PubMed ID: 28605495 [TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of nine South African medicinal plants in controlling Bacillus anthracis Sterne vaccine strain. Elisha IL; Dzoyem JP; Botha FS; Eloff JN BMC Complement Altern Med; 2016 Jan; 16():5. PubMed ID: 26742484 [TBL] [Abstract][Full Text] [Related]
34. Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus. Boudjemaa R; Cabriel C; Dubois-Brissonnet F; Bourg N; Dupuis G; Gruss A; Lévêque-Fort S; Briandet R; Fontaine-Aupart MP; Steenkeste K Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735564 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Esel D; Doganay M; Sumerkan B Int J Antimicrob Agents; 2003 Jul; 22(1):70-2. PubMed ID: 12842331 [TBL] [Abstract][Full Text] [Related]
36. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice. Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185 [TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth. Head BM; Alfa M; Sitar DS; Rubinstein E; Meyers AF J Antimicrob Chemother; 2017 Feb; 72(2):417-420. PubMed ID: 27798209 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. Mohammed MJ; Marston CK; Popovic T; Weyant RS; Tenover FC J Clin Microbiol; 2002 Jun; 40(6):1902-7. PubMed ID: 12037041 [TBL] [Abstract][Full Text] [Related]
40. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. Steenbergen JN; Alder J; Thorne GM; Tally FP J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]